Areas for action

0

Diagnosis and treatment

  • Better and more rapid diagnostic tools should be developed for both latent and active disease.
  • More effective vaccines should be developed for the prevention of active disease.
  • New highly active drugs are needed to treat resistant TB bacteria.
  • TB control programmes that are linked with HIV control programmes should be initiated, especially in countries where TB is still highly prevalent.

Research

  • The benefits of treatment of latent TB infection on the overall impact of TB in Europe need to be assessed.
  • The issue of genetic susceptibility to TB needs to be further investigated.
  • Tools should be developed to identify highly susceptible individuals

LEAVE A REPLY

Please enter your comment!
Please enter your name here